Jeenjoo Kang - Net Worth and Insider Trading

Jeenjoo Kang Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jeenjoo Kang owns 1 companies in total, including Tenaya Therapeutics Inc (TNYA) .

Click here to see the complete history of Jeenjoo Kang’s form 4 insider trades.

Insider Ownership Summary of Jeenjoo Kang

Ticker	Comapny	Transaction Date	Type of Owner
TNYA	Tenaya Therapeutics Inc	2021-07-29	director

Jeenjoo Kang Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jeenjoo Kang Ownership Network

Ownership Network List of Jeenjoo Kang

No Data

Ownership Network Relation of Jeenjoo Kang

Jeenjoo Kang Owned Company Details

What does Tenaya Therapeutics Inc do?

Who are the key executives at Tenaya Therapeutics Inc?

Jeenjoo Kang is the director of Tenaya Therapeutics Inc. Other key executives at Tenaya Therapeutics Inc include director & Chief Executive Officer Faraz Ali , Chief Medical Officer Whittemore Tingley , and Chief Scientific Officer Timothy Hoey .

Tenaya Therapeutics Inc (TNYA) Insider Trades Summary

Over the past 18 months, Jeenjoo Kang made no insider transaction in Tenaya Therapeutics Inc (TNYA). Other recent insider transactions involving Tenaya Therapeutics Inc (TNYA) include a net sale of 25,800 shares made by Timothy Hoey , a net sale of 21,669 shares made by Faraz Ali , and a net sale of 19,491 shares made by Whittemore Tingley .

In summary, during the past 3 months, insiders sold 19,539 shares of Tenaya Therapeutics Inc (TNYA) in total and bought 0 shares, with a net sale of 19,539 shares. During the past 18 months, 78,976 shares of Tenaya Therapeutics Inc (TNYA) were sold and 4,444,444 shares were bought by its insiders, resulting in a net purchase of 4,365,468 shares.

Tenaya Therapeutics Inc (TNYA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tenaya Therapeutics Inc Insider Transactions

No Available Data

Jeenjoo Kang Mailing Address

Above is the net worth, insider trading, and ownership report for Jeenjoo Kang. You might contact Jeenjoo Kang via mailing address: C/o Tenaya Therapeutics, Inc., 171 Oyster Point Boulevard, South San Francisco Ca 94080.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.